Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Medicines Company (MDCO)

Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Author
Pfizer and Sanofi shares fall, which one to scoop up? MarketBeat - Tue Nov 7, 2023

Pharmaceutical stocks aren't having a banner year; notably, two large pharmaceutical companies recently plunged to 52-week lows

PFE : 26.32 (+0.23%)
SNY : 47.69 (+1.15%)
SNYNF : 94.2500 (+1.67%)
SAN : 4.99 (+2.67%)
MDCO : 84.90 (-0.07%)
Author
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever? MarketBeat - Tue Sep 19, 2023

Eli Lilly & Co. stock has been on a tear, trading up 57.7% year-to-date on the strength of its industry-leading medications and highly-anticipated pipeline

LLY : 745.69 (+1.96%)
C : 62.67 (+2.82%)
NVO : 128.64 (+2.70%)
MDCO : 84.90 (-0.07%)
Author
7 Best Cancer Stocks to Invest in Now MarketBeat - Fri Jul 28, 2023

The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.

EXEL : 23.29 (+1.84%)
GILD : 67.03 (+0.12%)
NVS : 97.28 (+2.27%)
ON : 61.68 (+1.70%)
PFE : 26.32 (+0.23%)
MDCO : 84.90 (-0.07%)
MRK : 126.88 (-0.05%)
KURA : 18.73 (+2.97%)
AZN.LN : 11,404.000 (+1.21%)
BGNE : 138.99 (+6.15%)
Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives Business Wire - Mon May 10, 2021

Attralus Therapeutics today announced the appointment of Mark Timney as the company’s Chief Executive Officer and a member of its Board of Directors. Timney brings to Attralus more than 30 years of...

MDCO : 84.90 (-0.07%)
NVS : 97.28 (+2.27%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield? Barchart - Tue Apr 23, 6:30PM CDT
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot